Angiotensin receptor neprolysin inhibitors: a novel approach to prevent cardiorenal disease in diabetes mellitus. Berbari AE. J Hypertens 2020;38:608-609.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Berbari AE. Angiotensin receptor neprolysin inhibitors: a novel approach to prevent cardiorenal disease in diabetes mellitus. J Hypertens 2020;38:608-609.
PMID: 32132433